Can I read Biochips as Pathways to Drug Discovery (Drug Discovery Series Book 7) on EtoBox?

Biochips as Pathways to Drug Discovery (Drug Discovery Series Book 7) by Andrew Carmen (Editor), Gary Hardiman (Editor) is a nonfiction available to read on EtoBox.

What is Biochips as Pathways to Drug Discovery (Drug Discovery Series Book 7) about?

In the fiercely competitive pharmaceutical marketplace, your organization cannot afford to spend excess dollars developing drugs that will fail to get FDA approval or have profoundly poor characteristics. Biochips as Pathways to Drug Discovery takes a comprehensive look at how the industry faces these challenges, using new technologies such as biochips to reduce the cost of drug discovery and improve drug safety. The book explores the tools and skills required at each step of the discovery process when using biochips to determine biological outcomes. The authors provide an in-depth review of the clinical and pharmacogenomic relevance of biochips, ChIP-chip assays, and high-throughput approaches. They discuss how biochips are used to develop biomarkers in the drug discovery process, primarily for gene expression profiling and Single Nucleotide Polymorphism (SNP) analysis. The book includes coverage of experimental theory, quality control, clinical laboratory sampling considerations, database concepts, industrial laboratory design, and the analysis of the resultant large data sets. It discusses the application of biochips to the study of malaria, toxicogenomics, and SNPs, as well as

Who reads Biochips as Pathways to Drug Discovery (Drug Discovery Series Book 7)?

Author

Andrew Carmen (Editor), Gary Hardiman (Editor)

Publisher

CRC Press/Taylor & Francis Group

Published

2006

Language

EN

ISBN

9781280733581

Category

nonfiction

Subjects

Medical, Technology, Science